Page last updated: 2024-11-07

prednisone and Congenital Erythropoietic Porphyria

prednisone has been researched along with Congenital Erythropoietic Porphyria in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PECORELLA, F1
Lange, B1
Hofweber, K1
Waldherr, R1
Schärer, K1

Other Studies

2 other studies available for prednisone and Congenital Erythropoietic Porphyria

ArticleYear
[ON A NEW CASE OF CONGENITAL ERYTHROPOIETIC PORPHYRIA (GHUENTHER'S DISEASE)].
    La Pediatria, 1963, Dec-16, Volume: 71

    Topics: Anemia; Blood Chemical Analysis; Child; Humans; Liver Function Tests; Pathology; Porphyria, Erythrop

1963
Congenital erythropoietic porphyria associated with nephrotic syndrome and renal siderosis.
    Acta paediatrica (Oslo, Norway : 1992), 1995, Volume: 84, Issue:11

    Topics: Anti-Inflammatory Agents; Child; Deferoxamine; Glomerular Filtration Rate; Humans; Iron Chelating Ag

1995